(NASDAQ: CDNA) Caredx's forecast annual revenue growth rate of 9.77% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.64%.
Caredx's revenue in 2025 is $357,998,000.On average, 11 Wall Street analysts forecast CDNA's revenue for 2025 to be $19,589,149,216, with the lowest CDNA revenue forecast at $18,608,328,790, and the highest CDNA revenue forecast at $20,225,885,287. On average, 11 Wall Street analysts forecast CDNA's revenue for 2026 to be $21,939,620,818, with the lowest CDNA revenue forecast at $20,121,477,030, and the highest CDNA revenue forecast at $23,129,772,085.
In 2027, CDNA is forecast to generate $24,364,669,747 in revenue, with the lowest revenue forecast at $21,653,655,345 and the highest revenue forecast at $26,204,929,571.